LogoCrystal's MCW Coder Hub

E11.3312

34 min read

🧬ICD-10 CM E11.3312 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye

Short Definition

Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye

Long Definition

ICD-10-CM code E11.3312 identifies Type 2 diabetes mellitus complicated by moderate nonproliferative diabetic retinopathy (moderate NPDR) with concurrent macular edema specifically affecting the left eye. This diagnosis represents a chronic metabolic disorder (Type 2 diabetes) with significant microvascular complication affecting the retinal vasculature and macula. Type 2 diabetes mellitus, formerly known as adult-onset diabetes or non-insulin-dependent diabetes, is characterized by insulin resistance and relative insulin deficiency, typically developing in adults but increasingly seen in children and adolescents with obesity. The ophthalmic complication—moderate nonproliferative diabetic retinopathy—represents an intermediate stage of diabetic retinopathy where retinal microvascular changes are more extensive than mild NPDR but have not yet progressed to proliferative disease with neovascularization.

Moderate NPDR is characterized by more numerous microaneurysms, dot-blot and flame-shaped hemorrhages, cotton-wool spots (nerve fiber layer infarcts), venous beading, and intraretinal microvascular abnormalities (IRMA) compared to mild NPDR. The presence of macular edema (diabetic macular edema, DME) indicates fluid accumulation in the macula due to breakdown of the blood-retinal barrier, leakage from damaged retinal capillaries, and increased vascular permeability. Diabetic macular edema is the leading cause of vision loss in diabetic patients and can occur at any stage of diabetic retinopathy. The combination of moderate NPDR with macular edema indicates a vision-threatening condition requiring active treatment and close monitoring to prevent irreversible vision loss. This specific code denotes that the condition affects the left eye exclusively; if both eyes are involved, different codes must be used.

The diagnosis requires documentation by ophthalmologic examination including dilated fundus examination, optical coherence tomography (OCT), and often fluorescein angiography to assess the extent of retinopathy and macular edema. Treatment typically includes optimization of systemic diabetes control, blood pressure management, and ophthalmic interventions such as anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections, focal/grid laser photocoagulation, or both. This diagnosis has significant implications for risk adjustment and HCC coding, mapping to HCC 18 (Diabetes with Chronic Complications), which affects reimbursement in Medicare Advantage and ACA risk adjustment models.

Area of Body

Left eye retinal and macular structures, specifically:

Primary Affected Structure - Left Eye Retina:

  • Retinal vasculature:
    • Retinal capillaries (primary site of diabetic damage)
    • Arterioles and venules
    • Capillary basement membrane thickening
    • Pericyte loss
    • Endothelial cell damage
    • Microaneurysms (capillary outpouchings)
  • Retinal layers affected:
    • Inner retinal layers (supplied by retinal circulation)
    • Nerve fiber layer (cotton-wool spots represent infarction)
    • Ganglion cell layer
    • Inner plexiform layer
    • Inner nuclear layer (cystoid spaces with edema)
    • Outer plexiform layer (cystoid spaces with edema)
  • Macula (central retina):
    • Fovea (center of macula, responsible for sharp central vision)
    • Foveal avascular zone
    • Parafoveal region
    • Perifoveal region
    • Retinal thickness increased due to fluid accumulation
    • Intraretinal cystoid spaces
    • Subretinal fluid (may be present)

Specific Pathologic Findings in Moderate NPDR:

  • Microaneurysms: Multiple, scattered throughout posterior pole
  • Hemorrhages:
    • Dot-blot hemorrhages (deep retinal layers)
    • Flame-shaped hemorrhages (superficial nerve fiber layer)
    • More extensive than mild NPDR
  • Cotton-wool spots: Nerve fiber layer infarcts (fluffy white lesions)
  • Hard exudates: Lipid deposits from chronic leakage (yellow deposits)
  • Venous changes:
    • Venous beading (irregularity of venous caliber)
    • Venous loops
    • Venous dilation
  • Intraretinal microvascular abnormalities (IRMA): Dilated, tortuous intraretinal vessels
  • Retinal edema: Retinal thickening from fluid accumulation

Macular Edema Components:

  • Intraretinal fluid: Cystoid spaces in inner nuclear and outer plexiform layers
  • Subretinal fluid: Fluid under neurosensory retina (may be present)
  • Diffuse macular edema: Generalized thickening
  • Focal macular edema: Localized areas of thickening
  • Cystoid macular edema: Classic “petalloid” pattern of cystoid spaces
  • Central subfield thickness: Typically >300 microns (normal <250-300 microns)
  • Hard exudates: May form circinate patterns around leaking microaneurysms

Systemic Pathophysiology:

  • Hyperglycemia effects: Chronic elevated blood glucose damages vascular endothelium
  • Advanced glycation end-products (AGEs): Protein glycation causes vascular damage
  • Increased vascular permeability: VEGF upregulation
  • Inflammation: Cytokine release, leukostasis
  • Oxidative stress: Free radical damage
  • Blood-retinal barrier breakdown: Allows fluid leakage into retina

Clinical Presentation and Diagnosis

Patient Symptoms:

Visual Symptoms (May Be Asymptomatic in Early Moderate NPDR):

  • Blurred vision (from macular edema)
  • Distorted vision (metamorphopsia)
  • Difficulty reading
  • Central vision impairment
  • Colors appearing washed out
  • Fluctuating vision (worse with elevated blood sugars)
  • Many patients asymptomatic until significant macular edema develops

Associated Diabetic Symptoms:

  • Polyuria (frequent urination)
  • Polydipsia (increased thirst)
  • Polyphagia (increased hunger)
  • Fatigue
  • Unintentional weight loss or gain
  • Slow-healing wounds
  • Frequent infections
  • Peripheral neuropathy symptoms

Physical/Ophthalmologic Examination Findings:

Visual Function:

  • Visual acuity: May range from normal (20/20) to moderately reduced (20/40-20/200)
  • Best-corrected visual acuity depends on macular edema severity and location
  • Amsler grid: Central distortion or scotoma if macular edema present

Dilated Fundus Examination - Left Eye:

Moderate NPDR Findings (More Than Mild, Less Than Severe):

  • Microaneurysms: Numerous throughout posterior pole
  • Hemorrhages:
    • Moderate number (more than 20 hemorrhages in multiple quadrants)
    • Dot-blot hemorrhages (deep retinal)
    • Flame-shaped hemorrhages (superficial)
  • Cotton-wool spots: Present (1 or more)
  • Hard exudates: Yellow lipid deposits, may be circinate
  • Venous changes:
    • Mild venous beading (not meeting severe NPDR criteria)
    • Venous dilation or tortuosity
  • IRMA: May be present but not extensive (not meeting severe criteria)
  • No neovascularization: Absence of new vessels (differentiates from PDR)

Macular Edema Findings:

  • Retinal thickening in macular area
  • Loss of foveal depression
  • Cystoid spaces visible with OCT
  • Hard exudates in or around macula
  • Lipid ring formation

Severity Grading (ETDRS Classification):
Moderate NPDR defined as:

  • More than mild NPDR (more than microaneurysms alone)
  • Does NOT meet criteria for severe NPDR
  • Severe NPDR criteria (must have one of the following, which moderate NPDR does NOT meet):
    • Severe hemorrhages and microaneurysms in all 4 quadrants
    • Venous beading in 2+ quadrants
    • Moderate IRMA in 1+ quadrant
    • (“4-2-1 rule”)

Diagnostic Testing:

Essential Ophthalmologic Imaging:

  • Optical Coherence Tomography (OCT) - 92134:
    • Gold standard for diagnosing and quantifying macular edema
    • Measures central subfield thickness
    • Visualizes intraretinal cystoid spaces
    • Identifies subretinal fluid
    • Maps macular thickness
    • Quantifies edema for treatment monitoring
    • Typical findings: Central thickness >300 microns, cystoid spaces, increased retinal volume
  • Fundus Photography - 92250:
    • Documents retinal appearance
    • Baseline for comparison
    • Shows hemorrhages, exudates, cotton-wool spots
  • Fluorescein Angiography (FA) - 92235:
    • Identifies areas of capillary nonperfusion
    • Shows leakage from microaneurysms
    • Maps ischemic areas
    • Differentiates focal vs diffuse macular edema
    • Guides laser treatment planning
  • Fundus Autofluorescence:
    • Identifies RPE changes
    • May show areas of damage

Systemic Diabetes Monitoring:

  • Hemoglobin A1c (HbA1c):
    • Target <7% for most patients
    • Reflects 3-month average glucose control
    • Higher A1c associated with progression
  • Fasting blood glucose
  • Random blood glucose
  • Lipid panel: Dyslipidemia associated with hard exudates
  • Blood pressure: Hypertension accelerates retinopathy
  • Renal function: Creatinine, GFR (nephropathy often coexists with retinopathy)
  • Urinalysis: proteinuria/microalbuminuria

Visual Function Testing:

  • Visual acuity testing: Snellen or ETDRS charts
  • Contrast sensitivity: Often reduced with macular edema
  • Color vision testing: May be impaired
  • Visual field testing (92081-92083): If concerned about ischemia or other pathology

Differential Diagnosis:

  • Mild NPDR (less extensive changes)
  • Severe NPDR (meets 4-2-1 criteria)
  • Proliferative diabetic retinopathy (neovascularization present)
  • Other causes of macular edema (retinal vein occlusion, uveitis, age-related macular degeneration)
  • Pseudophakic cystoid macular edema
  • Epiretinal membrane

Includes

This Code Encompasses:

  • Type 2 diabetes mellitus (adult-onset, non-insulin-dependent diabetes)
  • Moderate stage nonproliferative diabetic retinopathy (intermediate severity)
  • Clinically significant macular edema present
  • Left eye specifically affected
  • Chronic diabetic complication
  • Microvascular complication of diabetes
  • Vision-threatening diabetic eye disease
  • Diabetic macular edema (DME) with moderate background retinopathy

Clinical Scenarios Included:

  • Type 2 diabetic patient with documented moderate NPDR findings on exam AND macular edema on OCT, left eye
  • Patient on insulin for Type 2 diabetes with moderate NPDR and DME, left eye
  • Patient on oral hypoglycemics with moderate NPDR and macular edema, left eye
  • Diet-controlled Type 2 diabetes with moderate NPDR and DME, left eye (if documented)
  • Type 2 diabetes with focal or diffuse macular edema in presence of moderate NPDR, left eye
  • Type 2 diabetes with clinically significant macular edema (CSME) and moderate NPDR, left eye

Required Documentation Elements:

  • Type 2 diabetes mellitus diagnosis
  • Moderate nonproliferative diabetic retinopathy confirmed by ophthalmologist
  • Macular edema documented (clinical exam and/or OCT)
  • Left eye specified

Excludes

Excludes1 (Cannot Code Together - Mutually Exclusive):

At E11 Category Level (Type 2 Diabetes):

  • E08.- Diabetes mellitus due to underlying condition (secondary diabetes from specific disease)
  • E09.- Drug or chemical induced diabetes mellitus (steroid-induced, medication-induced)
  • E10.- Type 1 diabetes mellitus (autoimmune, insulin-dependent)
  • E13.- Other specified diabetes mellitus (post-pancreatectomy, post-procedural, secondary NEC)
  • O24.4- Gestational diabetes (pregnancy-related)
  • P70.2 Neonatal diabetes mellitus

Within E11.33 (Moderate NPDR) - Cannot Code Different Laterality Together for Same Eye:

  • E11.3311 - Type 2 DM with moderate NPDR with macular edema, RIGHT eye (different eye)
  • E11.3313 - Type 2 DM with moderate NPDR with macular edema, BILATERAL (use this if both eyes have condition)
  • E11.3319 - Type 2 DM with moderate NPDR with macular edema, UNSPECIFIED eye

Cannot Code Different Severity Same Eye:

  • E11.3211 - Type 2 DM with MILD NPDR with macular edema, left eye (less severe)
  • E11.3412 - Type 2 DM with SEVERE NPDR with macular edema, left eye (more severe)
  • E11.3512 - Type 2 DM with PROLIFERATIVE diabetic retinopathy with macular edema, left eye (advanced stage)

Cannot Code With vs Without Macular Edema Same Eye:

  • E11.3392 - Type 2 DM with moderate NPDR WITHOUT macular edema, left eye (excludes macular edema)

If Macular Edema Resolved:

  • Once macular edema resolved with treatment, change to:
    • E11.3392 - Type 2 DM with moderate NPDR without macular edema, left eye
    • OR E11.37X2 - Type 2 DM with diabetic macular edema, resolved following treatment, left eye (if appropriate to document resolved edema history)

Documentation Rules:

  • Code the eye as documented by ophthalmologist
  • Code the severity stage as documented (mild, moderate, severe, proliferative)
  • Code presence or absence of macular edema as documented
  • Cannot code both “with macular edema” and “without macular edema” for same eye
  • If bilateral involvement, use bilateral code E11.3313, not separate right and left codes

HCC Status

HCC Mapping: HCC 18 - Diabetes with Chronic Complications

ICD-10 code E11.3312 DOES map to Hierarchical Condition Category 18 (Diabetes with Chronic Complications) under the CMS-HCC risk adjustment model.

HCC 18 Details:

  • Category: Diabetes with Chronic Complications
  • Risk Score Impact: Moderate to High
  • Community RAF (Risk Adjustment Factor): Approximately 0.302-0.318 (version-dependent)
  • Institutional RAF: Approximately 0.368 (version-dependent)
  • Relative Weight: Higher than uncomplicated diabetes (HCC 19) but lower than acute diabetes complications (HCC 17)

Diabetic HCC Hierarchy:
Three HCC categories exist for diabetes in a hierarchy:

  1. HCC 17 - Diabetes with Acute Complications (HIGHEST - TRUMPS all others)
  2. HCC 18 - Diabetes with Chronic Complications (MIDDLE) â—„ E11.3312 maps here
  3. HCC 19 - Diabetes without Complication (LOWEST)

Hierarchical Rule:

  • If patient has codes mapping to multiple diabetic HCCs, only the HIGHEST category counts for risk score
  • Example: If patient has E11.3312 (HCC 18) AND E11.65 (hyperglycemia, HCC 17 if with acute manifestation), only HCC 17 counts
  • If patient has E11.3312 (HCC 18) AND E11.9 (uncomplicated, HCC 19), only HCC 18 counts

Why E11.3312 Maps to HCC 18:

  • Diabetic retinopathy with macular edema represents CHRONIC microvascular complication
  • Requires ongoing monitoring and treatment
  • Associated with higher healthcare costs
  • Predicts future resource utilization
  • Vision-threatening condition requiring specialist care

All E11.3312 Coding Maps to HCC 18:

  • E11.33— (moderate NPDR with macular edema) → HCC 18
  • Any diabetic retinopathy code with specified severity → HCC 18
  • Diabetic macular edema → HCC 18

Clinical Documentation Requirements for HCC Capture:
To capture HCC 18, documentation must include:

  • Type 2 diabetes mellitus explicitly stated
  • Chronic complication specified (in this case, moderate NPDR with macular edema)
  • Link between diabetes and complication (diabetic retinopathy, diabetic macular edema)
  • Ophthalmologist documentation supporting retinopathy stage and macular edema
  • Annual documentation required - HCC must be documented at least once per calendar year to count in risk score

Best Documentation Practices for HCC:

  • Ophthalmologist should document: “Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye”
  • Primary care provider should document diabetes with ophthalmologic complication
  • Link complication to diabetes explicitly
  • Update annually with current status
  • Document ALL complications present (retinopathy, nephropathy, neuropathy each have separate HCC implications)

Impact on Reimbursement:

  • Medicare Advantage plans: Higher capitated payment for patients with HCC 18
  • ACA Marketplace plans: Risk adjustment payment
  • Accountable Care Organizations: Risk stratification
  • Value-based care models: Resource allocation

Coding for Risk Adjustment:

  • Code to highest specificity
  • E11.3312 is highly specific (includes diabetes type, complication type, severity, macular edema status, laterality)
  • More specific than E11.319 (unspecified diabetic retinopathy with macular edema)
  • HCC captured with E11.3312 coding

Other Diabetic Complications That May Co-exist:

  • E11.21 - Diabetic nephropathy → HCC 18
  • E11.22 - Diabetic CKD → HCC 138 (CKD) may also apply
  • E11.40-E11.49 - Diabetic neuropathy → HCC 18
  • E11.51-E11.59 - Diabetic peripheral circulatory complications → HCC 18 or HCC 108
  • E11.65 - Diabetes with hyperglycemia → HCC 17 if acute (TRUMPS HCC 18)
  • Code ALL applicable complications to maximize risk adjustment and accurately reflect patient complexity

wRVU Status

Not Applicable - ICD-10 diagnosis codes do not have wRVU (work Relative Value Units) values.

Note

wRVUs apply only to CPT procedure codes representing physician work performed. ICD-10 codes document the patient’s condition/diagnosis.

Related CPT Codes with wRVUs for Management of E11.3312:

Ophthalmology Examination:

  • 92002 - Ophthalmological services, intermediate, new patient: 0.92 wRVU
  • 92004 - Comprehensive, new patient: 1.50 wRVU
  • 92012 - Intermediate, established patient: 0.66 wRVU
  • 92014 - Comprehensive, established patient: 1.09 wRVU

Diagnostic Imaging (Essential for Monitoring):

  • 92250 - Fundus photography: 0.61 wRVU
  • 92134 - OCT retina (essential for macular edema): 0.52 wRVU
  • 92235 - Fluorescein angiography: 1.07 wRVU

Treatment Procedures:

  • 67028 - Intravitreal injection (anti-VEGF): 1.13 wRVU
    • Primary treatment for diabetic macular edema
    • Typical agents: Eylea, Lucentis, Avastin
  • 67210 - Photocoagulation, 1 or more sessions, focal: 6.50 wRVU
  • 67228 - Photocoagulation, 1 or more sessions, for diabetic retinopathy, focal or grid: 7.08 wRVU
  • 67229 - Photocoagulation, multiple lesions, 1 session: 9.79 wRVU (if treating PDR develops)

Primary Care/Endocrinology:

  • 99211-99215 - Office visits established: 0.18 to 1.92 wRVU
  • 99201-99205 - Office visits new: 0.92 to 3.17 wRVU
  • Diabetes management and optimization

Assistant Surgeon Status

Not Applicable - ICD-10 diagnosis codes do not have assistant surgeon payment policies.

Assistant surgeon policies apply to surgical CPT codes. E11.3312 is a diagnosis code.

Note: Treatment for moderate NPDR with macular edema typically does NOT require surgery. Management consists of:

  • Medical optimization of diabetes
  • Intravitreal anti-VEGF injections (67028 - not a surgical procedure requiring assistant)
  • Laser photocoagulation (67228 - not requiring assistant surgeon)
  • In rare cases requiring vitrectomy for complications, assistant surgeon policies would apply to vitrectomy codes (67036-67043), not to the diagnosis code

Common Modifiers

Not Applicable for Diagnosis Code

ICD-10 diagnosis codes do not use CPT modifiers. Modifiers are appended to CPT procedure codes.

Laterality Built Into Code:

  • E11.3312 = LEFT eye (laterality specified in code itself)
  • E11.3311 = RIGHT eye
  • E11.3313 = BILATERAL
  • No RT/LT modifiers needed on diagnosis code

When Billing CPT Procedures for E11.3312:
CPT codes may use modifiers:

  • -LT - Left side (use on procedure codes when treating left eye)
    • Example: 67028-LT (intravitreal injection, left eye)
    • Example: 92134-LT (OCT left eye) - though typically bilateral imaging code
  • -50 - Bilateral procedure (if treating both eyes)
  • -79 - Unrelated procedure during global period
  • -E1-E4 - Eyelid modifiers (if applicable to specific procedures)

Additional Code Requirements:
Must use additional codes to identify diabetes control/management:

  • Z79.4 - Long-term use of insulin (if on insulin)
  • Z79.84 - Long-term use of oral hypoglycemic drugs
  • Z79.85 - Long-term use of injectable non-insulin antidiabetic drugs (GLP-1 agonists, etc.)

Common Associated Codes

Related ICD-10 Diagnosis Codes:

ICD-10 CodeDescriptionRelationship to E11.3312
E11.3311Type 2 DM with moderate NPDR with macular edema, right eyeContralateral eye
E11.3313Type 2 DM with moderate NPDR with macular edema, bilateralUse if both eyes affected
E11.3319Type 2 DM with moderate NPDR with macular edema, unspecified eyeWhen laterality not documented
E11.3392Type 2 DM with moderate NPDR without macular edema, left eyeSame eye, no macular edema
E11.3211Type 2 DM with mild NPDR with macular edema, right eyeLess severe retinopathy
E11.3212Type 2 DM with mild NPDR with macular edema, left eyeLess severe retinopathy, same eye
E11.3412Type 2 DM with severe NPDR with macular edema, left eyeMore severe retinopathy, same eye
E11.3512Type 2 DM with proliferative diabetic retinopathy with macular edema, left eyeAdvanced stage, same eye
E11.3712Type 2 DM with diabetic macular edema, resolved following treatment, left eyeStatus post treatment
E11.319Type 2 DM with unspecified diabetic retinopathy with macular edemaLess specific
E11.21Type 2 DM with diabetic nephropathyCommon co-morbidity, HCC 18
E11.22Type 2 DM with diabetic chronic kidney diseaseCommon co-morbidity, HCC 18 + HCC 138
E11.40Type 2 DM with diabetic neuropathy, unspecifiedCommon co-morbidity, HCC 18
E11.42Type 2 DM with diabetic polyneuropathyCommon co-morbidity, HCC 18
E11.51Type 2 DM with diabetic peripheral angiopathy without gangreneVascular complication, HCC 18
E11.52Type 2 DM with diabetic peripheral angiopathy with gangreneSevere complication, HCC 106
E11.65Type 2 DM with hyperglycemiaPoor control, HCC 17 (trumps HCC 18)
E11.9Type 2 DM without complicationsUncomplicated, HCC 19 (lower hierarchy)
I10Essential hypertensionCommon co-morbidity
E78.5Hyperlipidemia, unspecifiedCommon co-morbidity
N18.30CKD stage 3Common with diabetic nephropathy, HCC 138
H35.81Retinal edemaMay code separately if needed
H36]]Retinal disorders in diseases classified elsewhereMay use as additional code
Z79.4Long-term use of insulinRequired additional code if on insulin
Z79.84Long-term use of oral hypoglycemic drugsRequired if on oral medications
Z79.85Long-term use of injectable non-insulin antidiabetic drugsIf on GLP-1 agonists

Common Associated CPT Procedure Codes:

CPT CodeDescriptionWhen Used with E11.3312
92002-92004Ophthalmological examination, new patientInitial evaluation
92012-92014Ophthalmological examination, established patientFollow-up visits (typically q3-4 months)
92134OCT retinaEssential for diagnosing and monitoring macular edema
92250Fundus photographyDocument retinopathy severity, baseline
92235Fluorescein angiographyIdentify leakage, guide treatment
67028Intravitreal injection (anti-VEGF)Primary treatment for diabetic macular edema
67210Laser photocoagulation, focalFocal macular edema treatment
67228Laser photocoagulation for diabetic retinopathyMacular grid laser or PRP if progresses
67229Laser photocoagulation, multiple lesionsIf extensive treatment needed
92081-92083Visual field examinationAssess vision function
99211-99215Office visit, established patientPrimary care diabetes management
99381-99387Preventive medicine visitsAnnual wellness visits
80047, 80048, 80050, 80053Metabolic panelsMonitor diabetes control, renal function
83036Hemoglobin A1cMonitor long-term glucose control (q3-6 months)
82947Glucose, quantitativeBlood sugar monitoring
80061Lipid panelCardiovascular risk management
84520Urea nitrogen (BUN)Monitor renal function
82565CreatinineMonitor renal function
82570Creatinine clearanceGFR assessment
81000-81003UrinalysisScreen for proteinuria/nephropathy
82042, 82043, 82044Albumin, urine microalbuminScreen for early nephropathy

Code Tree/Hierarchy

ICD-10-CM Chapter: 4 - Endocrine, Nutritional and Metabolic Diseases (E00-E89)

Block: E08-E13 - Diabetes mellitus

Category: E11 - Type 2 diabetes mellitus

Structure:

E11 - Type 2 diabetes mellitus
│
├── E11.0 - Type 2 diabetes mellitus with hyperosmolarity
├── E11.1 - Type 2 diabetes mellitus with ketoacidosis
├── E11.2 - Type 2 diabetes mellitus with kidney complications
│
├── E11.3 - Type 2 diabetes mellitus with ophthalmic complications ◄ Current Category
│   │
│   ├── E11.31 - Type 2 DM with unspecified diabetic retinopathy
│   │   ├── E11.311 - With macular edema
│   │   └── E11.319 - Without macular edema
│   │
│   ├── E11.32 - Type 2 DM with mild nonproliferative diabetic retinopathy
│   │   ├── E11.321 - With macular edema
│   │   │   ├── E11.3211 - Right eye
│   │   │   ├── E11.3212 - Left eye
│   │   │   ├── E11.3213 - Bilateral
│   │   │   └── E11.3219 - Unspecified eye
│   │   └── E11.329 - Without macular edema
│   │       ├── E11.3291]] - Right eye
│   │       ├── E11.3292]] - Left eye
│   │       ├── E11.3293]] - Bilateral
│   │       └── E11.3299]] - Unspecified eye
│   │
│   ├── E11.33 - Type 2 DM with moderate nonproliferative diabetic retinopathy ◄ Current Subcategory
│   │   ├── E11.331 - With macular edema ◄ Current Group
│   │   │   ├── E11.3311 - Right eye
│   │   │   ├── E11.3312 - Left eye ◄ CURRENT CODE
│   │   │   ├── E11.3313 - Bilateral
│   │   │   └── E11.3319 - Unspecified eye
│   │   └── E11.339 - Without macular edema
│   │       ├── E11.3391 - Right eye
│   │       ├── E11.3392 - Left eye
│   │       ├── E11.3393 - Bilateral
│   │       └── E11.3399 - Unspecified eye
│   │
│   ├── E11.34 - Type 2 DM with severe nonproliferative diabetic retinopathy
│   │   ├── E11.341 - With macular edema
│   │   │   ├── E11.3411 - Right eye
│   │   │   ├── E11.3412 - Left eye
│   │   │   ├── E11.3413 - Bilateral
│   │   │   └── E11.3419 - Unspecified eye
│   │   └── E11.349 - Without macular edema
│   │       ├── E11.3491 - Right eye
│   │       ├── E11.3492 - Left eye
│   │       ├── E11.3493 - Bilateral
│   │       └── E11.3499 - Unspecified eye
│   │
│   ├── E11.35 - Type 2 DM with proliferative diabetic retinopathy
│   │   ├── E11.351 - With macular edema
│   │   │   ├── E11.3511 - Right eye
│   │   │   ├── E11.3512 - Left eye
│   │   │   ├── E11.3513 - Bilateral
│   │   │   └── E11.3519 - Unspecified eye
│   │   ├── E11.352 - With traction retinal detachment involving the macula
│   │   ├── E11.353 - With traction retinal detachment not involving the macula
│   │   ├── E11.354 - With combined traction retinal detachment and rhegmatogenous retinal detachment
│   │   ├── E11.355 - With stable proliferative diabetic retinopathy
│   │   └── E11.359 - Without macular edema
│   │
│   ├── E11.36 - Type 2 DM with diabetic cataract
│   ├── E11.37 - Type 2 DM with diabetic macular edema, resolved following treatment
│   │   ├── E11.3711 - Right eye
│   │   ├── E11.3712 - Left eye
│   │   ├── E11.3713 - Bilateral
│   │   └── E11.3719 - Unspecified eye
│   └── E11.39 - Type 2 DM with other diabetic ophthalmic complication
│
├── E11.4 - Type 2 DM with neurological complications
├── E11.5 - Type 2 DM with circulatory complications
├── E11.6 - Type 2 DM with other specified complications
├── E11.8 - Type 2 DM with unspecified complications
└── E11.9 - Type 2 DM without complications

Code Selection Decision Tree for Diabetic Retinopathy:

Patient with Type 2 Diabetes?
│
├── Ophthalmic Complication Present?
│   │
│   ├── YES - Diabetic Retinopathy
│   │   │
│   │   ├── What is the SEVERITY?
│   │   │   ├── Unspecified → E11.31-
│   │   │   ├── Mild NPDR → E11.32-
│   │   │   ├── Moderate NPDR → E11.33- ◄ Current Level
│   │   │   ├── Severe NPDR → E11.34-
│   │   │   └── Proliferative DR → E11.35-
│   │   │
│   │   ├── Is MACULAR EDEMA Present?
│   │   │   ├── YES → E11.331- ◄ Current Group
│   │   │   └── NO → E11.339-
│   │   │
│   │   └── Which EYE Affected?
│   │       ├── Right eye → E11.3311
│   │       ├── Left eye → E11.3312 ◄ CURRENT CODE
│   │       ├── Bilateral → E11.3313
│   │       └── Unspecified → E11.3319
│   │
│   └── NO - No Retinopathy
│       └── E11.9 (if no other complications)
│
└── Document ALL diabetes complications present:
    - Retinopathy → E11.3--
    - Nephropathy → E11.21-E11.22
    - Neuropathy → E11.40-E11.49
    - Circulatory → E11.51-E11.59
    - Hyperglycemia → E11.65

Diabetic Retinopathy Severity Staging:

Diabetic Retinopathy Progression
│
├── NO DR → E11.9 (if no other complications)
│
├── MILD NPDR → E11.32-
│   - Microaneurysms only
│
├── MODERATE NPDR → E11.33- ◄ CURRENT CODE LEVEL
│   - More than microaneurysms
│   - Does NOT meet severe NPDR criteria
│   - Hemorrhages, cotton-wool spots, venous changes
│
├── SEVERE NPDR → E11.34-
│   - Meets "4-2-1 Rule":
│     - Severe hemorrhages/microaneurysms in 4 quadrants, OR
│     - Venous beading in 2+ quadrants, OR
│     - Moderate IRMA in 1+ quadrant
│
└── PROLIFERATIVE DR → E11.35-
    - Neovascularization of disc (NVD) or elsewhere (NVE)
    - Vitreous hemorrhage
    - Traction retinal detachment

Macular Edema Coding:

Is Macular Edema Present?
│
├── YES
│   ├── Clinically Significant Macular Edema (CSME)
│   ├── OCT confirms thickening >300 microns
│   ├── Intraretinal or subretinal fluid
│   └── Code: E11.33**1**- (with macular edema) ◄ E11.3312
│
└── NO
    ├── No macular thickening
    ├── OCT shows normal thickness <300 microns
    ├── No intraretinal or subretinal fluid
    └── Code: E11.33**9**- (without macular edema)

Coding Examples

Example 1: Initial Diagnosis of Moderate NPDR with Macular Edema

Clinical Scenario:
58-year-old female with Type 2 diabetes for 12 years presents to ophthalmology for routine diabetic eye examination. Patient reports vision in left eye “a little blurry” over past 2 months. No prior known retinopathy.

History:

  • Type 2 diabetes diagnosed 2004
  • Current medications: Metformin 1000mg BID, glargine insulin 30 units nightly
  • Last HbA1c: 8.2% (suboptimal control)
  • Last eye exam 18 months ago (overdue for annual exam)
  • Blood pressure: 142/88 (elevated)
  • No diabetic nephropathy or neuropathy documented

Ophthalmologic Examination - Left Eye:

  • Visual acuity: 20/40 OS (reduced from 20/25 at last visit)
  • Dilated fundus exam:
    • Numerous microaneurysms throughout posterior pole
    • Multiple dot-blot hemorrhages in 3 quadrants
    • 2 cotton-wool spots superior to disc
    • Hard exudates temporal to macula
    • Mild venous beading noted
    • No neovascularization
    • Assessment: Moderate nonproliferative diabetic retinopathy
  • Macular examination:
    • Retinal thickening noted clinically
    • Loss of foveal reflex

Right Eye:

  • Visual acuity: 20/25 OD
  • Mild NPDR: Few microaneurysms, minimal hemorrhages
  • No macular edema

OCT Left Eye:

  • Central subfield thickness: 425 microns (severely elevated; normal <300)
  • Intraretinal cystoid spaces in inner nuclear and outer plexiform layers
  • Increased macular volume
  • Diagnosis: Diabetic macular edema

Assessment:

  • Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye
  • Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye
  • Type 2 diabetes mellitus, poorly controlled

Plan:

  • Initiate anti-VEGF therapy (Eylea) for left eye macular edema
  • Monthly injections initially
  • Optimize diabetes control - refer to endocrinology
  • Improve blood pressure control
  • Return in 4 weeks for injection and reassessment

ICD-10-CM Coding:

  • E11.3312 - Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye (PRIMARY)
  • E11.3291 - Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye
  • E11.65 - Type 2 diabetes mellitus with hyperglycemia (HbA1c 8.2%, poorly controlled)
  • I10 - Essential hypertension
  • Z79.4 - Long-term use of insulin
  • Z79.84 - Long-term use of oral hypoglycemic drugs

CPT Coding:

  • 92014 - Comprehensive ophthalmological examination, established patient
  • 92134 - OCT retina
  • 92250 - Fundus photography
  • 67028-LT - Intravitreal injection, left eye (when performed)

HCC Impact:

  • E11.3312 → HCC 18 (Diabetes with Chronic Complications)
  • E11.65 → HCC 17 (Diabetes with Acute Complications) - TRUMPS HCC 18 in hierarchy
  • Only HCC 17 counts for risk score (higher)

Rationale:
E11.3312 appropriate as moderate NPDR documented with specific findings (more than microaneurysms, does not meet severe criteria), macular edema confirmed on OCT, left eye specified. Both eyes coded separately as different severity. Hyperglycemia coded as poor control. HCC 18 captured for risk adjustment (though trumped by HCC 17 if both present).

Example 2: Follow-up After Treatment - Macular Edema Resolved

Same Patient - 6 Months Later:

Clinical Scenario:
Patient returns for follow-up after 5 monthly Eylea injections to left eye. Reports vision improved.

Examination - Left Eye:

  • Visual acuity: 20/25 OS (improved from 20/40)
  • Dilated fundus exam:
    • Moderate NPDR findings persist (microaneurysms, hemorrhages, cotton-wool spots)
    • Hard exudates decreased
    • Macular appears flatter

OCT Left Eye:

  • Central subfield thickness: 265 microns (normal range, decreased from 425)
  • Intraretinal cystoid spaces resolved
  • Normal macular contour restored
  • Macular edema resolved

Assessment:

  • Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy WITHOUT macular edema, left eye (macular edema resolved following treatment)
  • Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye (stable)
  • Type 2 diabetes mellitus - improved control (HbA1c now 7.1%)

Plan:

  • Discontinue monthly injections
  • Monitor every 3 months with OCT
  • Continue optimized diabetes management

ICD-10-CM Coding - CHANGED from Initial Visit:

  • E11.3392 - Type 2 diabetes mellitus with moderate NPDR WITHOUT macular edema, left eye (changed from E11.3312)
  • OR E11.3712 - Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, left eye (alternative, documents treatment history)
  • E11.3291 - Type 2 DM with mild NPDR without macular edema, right eye (unchanged)
  • I10 - Essential hypertension
  • Z79.4 - Long-term use of insulin
  • Z79.84 - Long-term use of oral hypoglycemic drugs

CPT Coding:

  • 92012 - Intermediate examination, established
  • 92134 - OCT retina

HCC Impact:

  • E11.3392 or E11.3712 → Still HCC 18 (Diabetes with Chronic Complications)
  • Retinopathy persists even though macular edema resolved
  • HCC 18 still captured for risk adjustment

Rationale:
Code MUST change from E11.3312 to E11.3392 (or E11.3712) because macular edema no longer present. Cannot code “with macular edema” when edema resolved. Moderate NPDR findings persist, so severity stage unchanged. Still maps to HCC 18 because retinopathy is chronic complication.

Example 3: Bilateral Moderate NPDR with Macular Edema

Clinical Scenario:
65-year-old male with longstanding Type 2 diabetes, presents with blurred vision both eyes.

Examination - Both Eyes:

  • Visual acuity: 20/50 OU
  • Dilated fundus exam bilaterally:
    • Moderate NPDR findings: Multiple microaneurysms, hemorrhages in multiple quadrants, cotton-wool spots, hard exudates
    • No neovascularization
    • Macular edema clinically apparent both eyes

OCT - Bilateral:

  • Right eye: Central thickness 410 microns, cystoid spaces
  • Left eye: Central thickness 390 microns, cystoid spaces
  • Bilateral diabetic macular edema

Assessment:

  • Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, BILATERAL

Plan:

  • Bilateral anti-VEGF therapy
  • Alternate eyes monthly initially

ICD-10-CM Coding:

  • E11.3313 - Type 2 DM with moderate NPDR with macular edema, BILATERAL (PRIMARY)
  • Do NOT code E11.3311 AND E11.3312 separately
  • Z79.4 - Long-term use of insulin
  • Z79.84 - Long-term use of oral hypoglycemic drugs

CPT Coding:

  • 92014 - Comprehensive examination
  • 92134 - OCT retina (bilateral imaging)
  • 92250 - Fundus photography
  • 67028-RT - Intravitreal injection, right eye (first visit)
  • 67028-LT - Intravitreal injection, left eye (follow-up visit)

Rationale:
When both eyes have same condition, use BILATERAL code E11.3313, not separate right and left codes. More efficient and accurate. Still maps to HCC 18.

Example 4: Progression from Moderate to Severe NPDR

Clinical Scenario:
Patient with known moderate NPDR presents for follow-up. Examination reveals progression.

Prior Diagnosis (6 Months Ago):

  • E11.3312 - Moderate NPDR with macular edema, left eye

Current Examination - Left Eye:

  • Visual acuity: 20/60 OS (worsened)
  • Dilated fundus exam:
    • Severe retinal hemorrhages and microaneurysms in all 4 quadrants (“4” in 4-2-1 rule)
    • Venous beading in 2 quadrants (“2” in 4-2-1 rule)
    • Moderate IRMA in superior quadrant (“1” in 4-2-1 rule)
    • Meets criteria for SEVERE NPDR
    • No neovascularization yet

OCT:

  • Persistent macular edema: Central thickness 380 microns

Assessment:

  • Type 2 diabetes mellitus with SEVERE nonproliferative diabetic retinopathy with macular edema, left eye (PROGRESSION)

Plan:

  • Continue anti-VEGF therapy
  • Consider panretinal photocoagulation (PRP) to prevent progression to PDR
  • Close monitoring

ICD-10-CM Coding - CHANGED:

  • E11.3412 - Type 2 DM with SEVERE NPDR with macular edema, left eye (CHANGED from E11.3312)
  • Z79.4 - Long-term use of insulin

Rationale:
Code must be updated to reflect progression from moderate (E11.33—) to severe (E11.34—) NPDR. Severity level changed based on meeting 4-2-1 criteria. Macular edema persists. Still maps to HCC 18.

Example 5: Documentation Insufficiency - Cannot Code E11.3312

Clinical Scenario:
Patient chart states: “Patient has diabetes with eye problems, left eye blurry.”

Inadequate Documentation:

  • Type of diabetes not specified (Type 1 vs Type 2)
  • Retinopathy severity not documented (mild, moderate, severe, PDR?)
  • Macular edema not confirmed (clinical impression vs OCT?)
  • No ophthalmology examination documented

Cannot Code E11.3312 Because:

  • Requires Type 2 diabetes explicitly stated
  • Requires moderate NPDR documented by ophthalmologist
  • Requires macular edema confirmed
  • Requires left eye specified

Query Physician:

  • “Please document type of diabetes (Type 1 or Type 2)”
  • “Please specify diabetic retinopathy severity based on ophthalmology findings”
  • “Please confirm presence or absence of macular edema based on OCT”
  • “Please specify which eye affected”

If No Response to Query:
Must code less specifically:

  • E11.319 - Type 2 DM with unspecified diabetic retinopathy with macular edema (if macular edema confirmed but severity not specified)
  • OR E11.9 - Type 2 DM without complications (if retinopathy not confirmed)

Rationale:
E11.3312 is highly specific code requiring detailed ophthalmologic documentation. Cannot assume moderate severity or macular edema without explicit documentation. Accurate coding requires complete documentation.

Example 6: HCC Documentation and Risk Adjustment

Clinical Scenario:
Annual wellness visit for Medicare Advantage patient with history of diabetic retinopathy.

Documentation by Primary Care Provider:
“Patient has history of diabetes with eye complications. Last saw ophthalmology 8 months ago.”

Problem:

  • HCC requires ANNUAL documentation to count in risk score
  • “History of” does not capture HCC unless current active condition documented
  • Insufficient documentation to capture HCC 18

Improved Documentation:
Provider should document: “Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye, currently under treatment with monthly anti-VEGF injections. Patient followed by ophthalmology. Retinopathy remains active chronic complication requiring ongoing monitoring and treatment.”

Coding:

  • E11.3312 - Type 2 DM with moderate NPDR with macular edema, left eye (HCC 18 CAPTURED)
  • Z79.4 - Long-term use of insulin

HCC Impact:

  • With improved documentation: HCC 18 captured → RAF approximately 0.302-0.318 added to patient risk score
  • Without specific documentation: HCC 18 NOT captured → Loss of risk adjustment payment

Best Practices:

  • Document ALL active chronic complications annually
  • Use specific ICD-10 codes to highest specificity
  • Link complications to diabetes explicitly
  • Document ongoing treatment and monitoring
  • Review prior ophthalmology notes and incorporate findings into annual assessment

Rationale:
HCC coding requires active documentation annually. “History of” insufficient unless documented as current active condition requiring ongoing management. Accurate HCC capture ensures appropriate reimbursement for patient complexity.

Documentation Requirements

Complete Documentation Must Include:

1. Type of Diabetes:

  • Explicitly state “Type 2 diabetes mellitus”
  • Cannot assume from medications alone
  • Distinguish from Type 1, secondary, gestational

2. Diabetic Retinopathy Severity:
Must be documented by ophthalmologist or optometrist:

  • “Moderate nonproliferative diabetic retinopathy” or “Moderate NPDR”
  • Cannot code moderate severity based on:
    • Patient report
    • Non-specific “diabetic retinopathy”
    • “Background retinopathy” (outdated term)

Documentation should describe findings:

  • Number and distribution of microaneurysms
  • Presence and extent of hemorrhages
  • Cotton-wool spots
  • Hard exudates
  • Venous changes (beading, loops, dilation)
  • IRMA (intraretinal microvascular abnormalities)
  • Explicitly state does NOT meet severe NPDR criteria (no 4-2-1)
  • Explicitly state no neovascularization present (rules out PDR)

3. Macular Edema:
Must be documented:

  • Clinical examination: “Macular edema present” or “Retinal thickening in macula”
  • OCT documentation: Central subfield thickness measurement, presence of intraretinal or subretinal fluid
  • Fluorescein angiography (if performed): Leakage documented

OCT findings should specify:

  • Central subfield thickness (number in microns)
  • Presence of cystoid spaces
  • Location of fluid (intraretinal, subretinal)
  • Comparison to prior if available

4. Laterality:

  • Must specify “left eye,” “right eye,” or “bilateral”
  • Cannot use unspecified eye code when laterality known
  • Document OS, OD, or OU

5. Link to Diabetes:

  • Document that retinopathy and macular edema are DIABETIC in origin
  • “Diabetic macular edema” not just “macular edema”
  • “Diabetic retinopathy” linking to patient’s diabetes

Complete Documentation Example:
“Patient has Type 2 diabetes mellitus complicated by moderate nonproliferative diabetic retinopathy in the left eye. Dilated fundus examination reveals multiple microaneurysms, dot-blot hemorrhages in three quadrants, two cotton-wool spots, and hard exudates temporal to the macula. Venous beading is mild. No intraretinal microvascular abnormalities approaching severe NPDR criteria are present (does not meet 4-2-1 rule). No neovascularization is identified. OCT of the left eye demonstrates diabetic macular edema with central subfield thickness of 405 microns (normal <300 microns) and intraretinal cystoid spaces in the inner nuclear and outer plexiform layers. Diagnosis: Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye.”

Additional Documentation for Complete Picture:

Diabetes Control:

  • HbA1c value and date
  • Blood glucose levels
  • Current diabetes medications
  • Compliance with treatment
  • Recent changes in diabetes management

Diabetes Medications (Require Additional Codes):

  • If on insulin: Document “Patient on long-term insulin therapy” → Code Z79.4
  • If on oral medications: Document “Patient on metformin” or other oral agent → Code Z79.84
  • If on injectable non-insulin: Document “Patient on Ozempic” or other GLP-1 → Code Z79.85

Other Diabetic Complications:
Document ALL complications present:

  • Diabetic nephropathy/CKD (E11.21, E11.22)
  • Diabetic neuropathy (E11.40-E11.49)
  • Diabetic peripheral vascular disease (E11.51, E11.52)
  • Poor control/hyperglycemia (E11.65)

Treatment Plan:

  • Anti-VEGF injection therapy planned/received
  • Laser photocoagulation planned/performed
  • Frequency of ophthalmology follow-up
  • Plan for optimizing diabetes control
  • Blood pressure management

Annual Documentation Requirement:

  • For HCC capture, must document annually (each calendar year)
  • “History of diabetic retinopathy” insufficient unless documented as current active condition
  • Review prior ophthalmology records
  • Document current status even if stable

Coding from Ophthalmology Notes:
Primary care providers and hospitalists can code from ophthalmology documentation:

  • Review ophthalmology consultation notes
  • Incorporate findings into assessment/plan
  • Document: “Per ophthalmology, patient has moderate NPDR with macular edema, left eye, currently under treatment”
  • Ensures HCC capture at all encounters

Billing and Coding Considerations

Primary Diagnosis Usage:

  • E11.3312 should be included on ALL encounters for patients with this condition
  • May be primary or secondary diagnosis depending on encounter reason
  • For ophthalmology visits: PRIMARY diagnosis
  • For primary care diabetes management visits: PRIMARY or high on list
  • For hospitalizations: Include in problem list, may be secondary to admission diagnosis

HCC Coding Requirements:

Annual Documentation Mandate:

  • Must be documented at least ONCE per calendar year to count in risk score
  • Best practice: Document at EVERY encounter
  • January 1 resets HCC capture - ensure documented early in year
  • Year-end visits critical for HCC capture

Who Can Document for HCC:

  • Ophthalmologist (ideal)
  • Optometrist
  • Primary care physician (can document from ophthalmology records)
  • Endocrinologist
  • Hospitalist (during admissions)
  • Any qualified provider documenting in medical record

Documentation Tips for HCC:

  • Use full ICD-10 code description in assessment
  • “Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye”
  • Link to diabetes explicitly
  • Document ongoing treatment and monitoring
  • Note chronic nature of complication
  • Reference ophthalmology records

Hierarchical Rule Application:
Patient may have multiple diabetes codes:

  • E11.3312 (moderate NPDR with DME) → HCC 18
  • E11.22 (diabetic CKD) → HCC 18 + HCC 138
  • E11.65 (hyperglycemia) → HCC 17 (TRUMPS HCC 18)

Result: Only HCC 17 counts for diabetic HCC hierarchy, BUT HCC 138 (CKD) counts separately

  • Always code ALL complications present
  • Let payer software apply hierarchical rules
  • More complete coding = more accurate risk adjustment

Medical Necessity for Services:

Ophthalmology Visits:

  • E11.3312 supports:
    • Comprehensive eye examinations (92004, 92014)
    • Frequent follow-up visits (typically q3-4 months or monthly if on injections)
    • OCT imaging (92134) - essential for monitoring
    • Fundus photography (92250)
    • Fluorescein angiography (92235) - when indicated
    • Anti-VEGF intravitreal injections (67028) - primary treatment
    • Laser photocoagulation (67228) - grid or focal laser

Primary Care Visits:

  • Supports frequent diabetes management visits
  • Justifies diabetes care management codes (99490, 99487-99489)
  • Supports chronic care management
  • Justifies comprehensive metabolic panels, HbA1c monitoring

Frequency Guidelines:

  • Ophthalmology visits: Typically q3-4 months, or monthly if on injection therapy
  • More frequent if unstable or progressing
  • OCT at each visit medically necessary to monitor macular edema
  • No specific Medicare frequency limit, but must be medically reasonable

Billing with Anti-VEGF Injections:

Typical Treatment Pattern:

  • Initial visit: Examination (92014), OCT (92134), injection (67028)
  • Follow-up visits (monthly initially): Brief exam (92012), OCT (92134), injection (67028)
  • Once stable: Extend to PRN or Q2-3 month injections with monitoring

Example Billing:

  • 92012 - Intermediate examination
  • 92134 - OCT retina
  • 67028-LT - Intravitreal injection, left eye
  • J0178 - Aflibercept (Eylea) 2mg
  • Link all to E11.3312

Drug Billing:

  • J0178 (Eylea/Aflibercept)
  • J2778 (Ranibizumab/Lucentis)
  • J9035 (Bevacizumab/Avastin)
  • Q5107 (Bevacizumab-awwb biosimilar)
  • Dose billed based on actual amount administered

Payer Considerations:

Medicare:

  • Covers medically necessary treatment for diabetic retinopathy with macular edema
  • Anti-VEGF injections covered for DME
  • Laser photocoagulation covered
  • OCT monitoring covered (reasonable frequency)
  • No specific visit frequency limit but must be medically reasonable

Medicare Advantage:

  • HCC 18 increases capitated payment to plan
  • Plans may have care management programs for diabetic retinopathy
  • May require prior authorization for anti-VEGF (check plan)
  • Some plans have value-based arrangements with retina specialists

Commercial Insurance:

  • Variable coverage policies
  • Most cover anti-VEGF for DME
  • May require prior authorization for injections
  • Step therapy possible (must try one agent before another)
  • Quantity limits on injections (typically 12-14 per eye per year)

Medicaid:

  • Covers medically necessary treatment
  • May require prior authorization
  • State-specific policies

Common Billing Errors to Avoid:

  1. Using less specific code when more specific available:
    • Using E11.319 (unspecified DR with DME) when severity known
    • Using E11.39 (other ophthalmic complication)
    • Must use E11.3312 when moderate NPDR documented
  2. Wrong laterality:
    • E11.3311 (right eye) vs E11.3312 (left eye) vs E11.3313 (bilateral)
    • Code as documented
  3. Coding macular edema when not present:
    • E11.3312 (WITH macular edema) requires OCT confirmation
    • If resolved, change to E11.3392 (WITHOUT macular edema)
    • Cannot code “with macular edema” without documentation
  4. Wrong severity stage:
    • Mild (E11.32—) vs Moderate (E11.33—) vs Severe (E11.34—) vs Proliferative (E11.35—)
    • Code as documented by ophthalmologist
    • Cannot assume severity
  5. Not updating code when condition changes:
    • If progresses to severe or PDR, must update code
    • If macular edema resolves, must update code
    • Annual reassessment and code update required
  6. Missing Z79 codes for diabetes medications:
    • Z79.4 (insulin) - required if on insulin
    • Z79.84 (oral hypoglycemics) - required if on oral meds
    • Z79.85 (injectable non-insulin) - if on GLP-1 agonists
  7. Not coding all diabetic complications:
    • Code ALL complications present for complete picture
    • Retinopathy, nephropathy, neuropathy can all coexist
    • Each impacts HCC capture and reimbursement
  8. Not documenting annually for HCC:
    • HCC requires annual documentation
    • Documenting only at ophthalmology visits insufficient if no ophthalmology visit in calendar year
    • Primary care must document from ophthalmology records

Best Practices:

Documentation:

  • Complete, specific documentation by ophthalmologist
  • Primary care incorporates ophthalmology findings into annual visit documentation
  • Document severity, macular edema status, laterality
  • Link to diabetes explicitly
  • Document treatment plan and response

Coding:

  • Code to highest specificity (E11.3312 vs less specific codes)
  • Code all diabetic complications present
  • Update codes as condition changes
  • Include Z79 medication codes
  • Ensure annual documentation for HCC

Medical Necessity:

  • Justify frequency of visits and testing
  • Document treatment response or lack thereof
  • Note changes from prior visits
  • OCT comparison to prior essential

Quality Measures:

  • Diabetic retinopathy screening/monitoring impacts HEDIS/quality measures
  • Annual ophthalmology examination for diabetic patients
  • HbA1c control
  • Blood pressure control
  • Document compliance with quality initiatives

This completes the comprehensive documentation for ICD-10-CM code E11.3312.

Graph View

Recent Notes